Cryo-Cell International Receives Renewed FACT Accreditation For Cord Blood Collection, Banking And Release For Administration Donations; Re-Accreditation Extends Through April 3, 2029
Cryo-Cell International Q1 EPS $0.01 Beats $(0.10) Estimate, Sales $7.683M Beat $7.631M Estimate
Cryo-Cell International Receives Noncompliance Notice From NYSE
Cryo-Cell International Q4 EPS $(0.13) Misses $(0.11) Estimate, Sales $7.843M Beat $7.731M Estimate
12 Health Care Stocks Moving In Wednesday's After-Market Session
Maxim Group Downgrades Cryo-Cell International to Hold
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results
Cryo-Cell International Q3 EPS $0.09 Beats $(0.05) Estimate, Sales $7.830M Miss $7.981M Estimate
[Latest] Global Umbilical Cord Blood Banking Market Size/Share Worth USD 51.67 Billion by 2034 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Cryo-Cell International, Inc. Provides Dividend Update
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results
Cryo-Cell International Q2 EPS $0.04 Beats $(0.05) Estimate, Sales $7.929M Miss $8.041M Estimate
Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results
Cryo-Cell International Q1 2025 GAAP EPS $0.03 Beats $0.02 Estimate, Sales $7.97M Miss $8.04M Estimate
Maxim Group Maintains Buy on Cryo-Cell International, Lowers Price Target to $8.5
Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives
Cryo-Cell Pauses Strategic Initiatives Relating To Possible Sale Or Merger
Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.